Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors
Clinical trial NCT06031480 · UNKNOWN
Trial details
- NCT number
- NCT06031480
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-31
- Primary completion
- 2025-10-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.